References
Original article
Kalantar-Zadeh, K. et al. Effect of apabetalone on cardiovascular events in diabetes, CKD, and recent acute coronary syndrome: results from the BETonMACE randomized controlled trial. Clin. J. Am. Soc. Nephrol. 16, 705–716 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allison, S. Apabetalone in chronic kidney disease. Nat Rev Nephrol 17, 437 (2021). https://doi.org/10.1038/s41581-021-00443-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-021-00443-1
- Springer Nature Limited